SCHEMBL26358357

SCHEMBL26358357

Cc1cccc(Cc2ccnc(Cl)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 1/20 0.50
▸ LOX P28300 1/20 0.50
▸ LOXL3 P58215 1/20 0.50
▸ LOXL2 Q9Y4K0 1/20 0.50
▸ NR3C2 P08235 1/20 0.47
▸ MAPK14 Q16539 1/20 0.45
▸ CYP1A2 P05177 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ KDM5B Q9UGL1 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ TAAR1 Q96RJ0 1/20 0.42
▸ LTA4H P09960 1/20 0.41
▸ KCNN3 Q9UGI6 1/20 0.41
▸ IDO1 P14902 2/20 0.41
▸ CYP11B1 P15538 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ MPO P05164 1/20 0.40
▸ DAO P14920 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24349558 0.82 RECQL (0.57) RECQLLOXLOXL3LOXL2NR3C2
SCHEMBL29459538 0.79 TAAR1 (0.60) TAAR1LTA4HIDO1DAOALDH1A1
SCHEMBL30000562 0.79 TAAR1 (0.60) TAAR1LTA4HIDO1DAOALDH1A1
SCHEMBL1263547 0.79 TAAR1 (0.60) TAAR1LTA4HIDO1DAOALDH1A1
SCHEMBL27160513 0.79 RECQL (0.46) RECQLLOXLOXL3LOXL2CYP2C19
SCHEMBL31288127 0.79 HTR1B (0.50) RECQLLOXLOXL3LOXL2NR3C2
SCHEMBL27160473 0.79 RECQL (0.46) RECQLLOXLOXL3LOXL2MAPK14
SCHEMBL11539964 0.78 LTA4H (0.49) NR3C2CYP3A4TAAR1LTA4HIDO1
SCHEMBL25177952 0.77 TAAR1 (0.43) NR3C2CYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL27160505 0.76 RECQL (0.44) RECQLLOXLOXL3LOXL2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773065-B2 Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-10-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773065-B2 Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists GPR52, GPR68, GPR65 RECQL 4518/4885LOX 3173/4885LOXL3 2324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback